QMA

Immunome, Inc. (IMNM) — QMA analysis

Sector: Healthcare · Market cap: $2.3B · Price: $18,26 · Data as of 2026-10-22

48
/100
C
Composite grade
Higher score than 64% of 22,733 tracked stocks

A composite score of 48/100 places Immunome, Inc. in the neutral band, higher score than 64% of 22,733 tracked stocks. The highest-scoring layer is Earnings quality; the lowest is Insider activity.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.

What 12 data layers say about IMNM

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)34/100
Earnings quality (EQS)100/100
Technical trend (TSS)45/100
Relative strength (RS)34/100
Momentum (USS)39/100
Insider activity (IAS)19/100
Off-exchange trading (FINRA) / large flows (WHS)37/100
Institutional 13F (IFS)65/100
Options flow (OFS)63/100
News sentiment (NSS)67/100
Analysts / transcripts (ATS)90/100
Catalysts (XS)33/100

What does the QMA model currently show for Immunome, Inc.?

The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.

For IMNM the layers diverge — some score high (Earnings quality), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

IMNM insider & smart money activity

Over the recent period we record 12 reported insider purchases and 20 sales for IMNM: mixed picture. A description of the data layer, not an instruction.

IMNM seasonality

The historically strong window for IMNM was January 1–28 with a hit rate of 83% and an average move of 24.8% (7 years of history).

Historical data does not guarantee future results.

How IMNM compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for IMNM stock?

48/100 (C) — Data as of 2026-10-22.

Are insiders buying IMNM stock?

Over the recent period, reported: purchases 12, sales 20 (purchases $20.4M, sales $15.4M). Insider activity: mixed picture — a description of reported data, not a trade instruction.

Where can I see live IMNM data?

Live IMNM data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.

Free registration, no card — trial full access, then the free plan

Open IMNM detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]